Tenet Healthcare (THC) Stock Forecast, Price Target & Predictions
THC Stock Forecast
Tenet Healthcare (THC) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $259.50, with a high of $288.00 and a low of $210.00. This represents a 49.85% increase from the last price of $173.17.
THC Stock Rating
Tenet Healthcare stock's rating consensus is Buy, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 26 Buy (81.25%), 6 Hold (18.75%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
THC Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Tenet Healthcare | 49.85% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Medical Care Facilities Stocks | 26.90% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 4 | 31 |
| Avg Price Target | - | $240.50 | $246.68 |
| Last Closing Price | $173.17 | $173.17 | $173.17 |
| Upside/Downside | - | 38.88% | 42.45% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Jun, 26 | 6 | 14 | 2 | - | - | 22 |
| May, 26 | 6 | 14 | 2 | - | - | 22 |
| Apr, 26 | 6 | 14 | 2 | - | - | 22 |
| Mar, 26 | 5 | 14 | 3 | - | - | 22 |
| Feb, 26 | 5 | 14 | 3 | - | - | 22 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 05, 2026 | Robert W. Baird | $210.00 | $185.35 | 13.30% | 21.27% | |
| May 05, 2026 | Andrew Mok | Barclays | $238.00 | $185.35 | 28.41% | 37.44% |
| May 04, 2026 | Scott Fidel | Stephens | $260.00 | $183.27 | 41.87% | 50.14% |
| May 01, 2026 | Morgan Stanley | $254.00 | $183.95 | 38.08% | 46.68% | |
| Mar 12, 2026 | Jason Cassorla | Guggenheim | $283.00 | $234.58 | 20.64% | 63.42% |
| Feb 17, 2026 | Truist Financial | $270.00 | $232.06 | 16.35% | 55.92% | |
| Feb 16, 2026 | Stephen Baxter | Wells Fargo | $265.00 | $231.10 | 14.67% | 53.03% |
| Feb 13, 2026 | Guggenheim | $271.00 | $232.26 | 16.68% | 56.49% | |
| Feb 13, 2026 | Andrew Mok | Barclays | $257.00 | $232.26 | 10.65% | 48.41% |
| Feb 12, 2026 | UBS | $288.00 | $233.50 | 23.34% | 66.31% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 05, 2026 | Barclays | Overweight | Overweight | hold |
| May 04, 2026 | Stephens | Overweight | Overweight | hold |
| Mar 12, 2026 | Guggenheim | Buy | Buy | hold |
| Mar 04, 2026 | Cantor Fitzgerald | Overweight | Overweight | hold |
| Feb 16, 2026 | Wells Fargo | Overweight | Overweight | hold |
| Feb 13, 2026 | Guggenheim | Buy | Buy | hold |
| Feb 13, 2026 | Barclays | Overweight | Overweight | hold |
| Feb 12, 2026 | Cowen & Co. | Buy | Buy | hold |
| Feb 12, 2026 | Morgan Stanley | Overweight | Overweight | hold |
| Feb 12, 2026 | KeyBanc | Overweight | Overweight | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|
| Reported | $8.55 | $3.84 | $6.01 | $33.02 | $15.61 | - | - |
| Avg Forecast | $6.23 | $6.12 | $5.84 | $11.32 | $11.42 | $12.94 | $14.30 |
| High Forecast | $6.48 | $6.37 | $6.06 | $11.46 | $12.93 | $15.70 | $14.87 |
| Low Forecast | $6.13 | $5.98 | $5.70 | $11.13 | $10.53 | $11.37 | $13.73 |
| Surprise % | 37.24% | -37.25% | 2.91% | 191.70% | 36.69% | - | - |
Revenue Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|
| Reported | $19.48B | $19.17B | $20.55B | $20.66B | $21.31B | - | - |
| Avg Forecast | $19.62B | $19.10B | $20.45B | $20.77B | $21.25B | $22.28B | $23.22B |
| High Forecast | $20.24B | $19.69B | $20.59B | $20.86B | $21.71B | $22.34B | $23.37B |
| Low Forecast | $19.37B | $18.75B | $20.39B | $20.71B | $20.87B | $22.22B | $23.07B |
| Surprise % | -0.70% | 0.39% | 0.48% | -0.53% | 0.29% | - | - |
Net Income Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|
| Reported | $914.00M | $411.00M | $611.00M | $3.20B | $1.41B | - | - |
| Avg Forecast | $790.01M | $909.11M | $611.00M | $1.18B | $1.23B | $1.42B | $1.50B |
| High Forecast | $948.01M | $1.09B | $733.20M | $1.20B | $1.35B | $1.65B | $1.56B |
| Low Forecast | $632.01M | $727.29M | $488.80M | $1.17B | $1.10B | $1.19B | $1.44B |
| Surprise % | 15.70% | -54.79% | - | 170.30% | 14.48% | - | - |